Login / Signup

Cost Savings of Whole Blood Versus Component Therapy at a Community Level 1 Trauma Center.

Rachel C MurphyTyler W JohnsonThomas J MackRachel E BurkeNicholas P DamianoLaura HegerNicholas MinnerEmily GermanAngela WilsonMichael G MountBrian C ThurstonCaleb J Mentzer
Published in: The American surgeon (2024)
Despite increased patient volumes over the study period (43.7%), the utilization of WB as compared to CORe resulted in an overall $3.39 million cost savings while improving mortality. As such, we propose WB should be utilized in all resuscitation strategies for the exsanguinating trauma patient.
Keyphrases
  • case report
  • cardiac arrest
  • healthcare
  • mental health
  • trauma patients
  • risk factors
  • cardiovascular disease
  • coronary artery disease
  • mesenchymal stem cells
  • cell therapy
  • septic shock
  • replacement therapy